These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21624783)

  • 1. The epidemiological dynamics of infectious trachoma may facilitate elimination.
    Lietman TM; Gebre T; Ayele B; Ray KJ; Maher MC; See CW; Emerson PM; Porco TC;
    Epidemics; 2011 Jun; 3(2):119-24. PubMed ID: 21624783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
    BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ocular chlamydia after three mass azithromycin distributions.
    Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Travel and implications for the elimination of trachoma in ethiopia.
    Shah NA; House J; Lakew T; Alemayehu W; Halfpenny C; Hong KC; Keenan JD; Porco TC; Whitcher JP; Lietman TM; Gaynor BD
    Ophthalmic Epidemiol; 2010 Mar; 17(2):113-7. PubMed ID: 20302432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Chlamydia trachomatis infection: elimination with mass drug administration.
    Wolle MA; West SK
    Expert Rev Anti Infect Ther; 2019 Mar; 17(3):189-200. PubMed ID: 30698042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
    Ray KJ; Lietman TM; Porco TC; Keenan JD; Bailey RL; Solomon AW; Burton MJ; Harding-Esch E; Holland MJ; Mabey D
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e458. PubMed ID: 19529761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics for trachoma.
    Evans JR; Solomon AW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001860. PubMed ID: 21412875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.
    Gambhir M; Basáñez MG; Burton MJ; Solomon AW; Bailey RL; Holland MJ; Blake IM; Donnelly CA; Jabr I; Mabey DC; Grassly NC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e462. PubMed ID: 19529762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
    N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
    Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
    PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
    Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trachoma: transmission, infection, and control.
    Gambhir M; Basáñez MG; Turner F; Kumaresan J; Grassly NC
    Lancet Infect Dis; 2007 Jun; 7(6):420-7. PubMed ID: 17521595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical Modelling of Trachoma Transmission, Control and Elimination.
    Pinsent A; Blake IM; Basáñez MG; Gambhir M
    Adv Parasitol; 2016; 94():1-48. PubMed ID: 27756453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
    Melese M; Chidambaram JD; Alemayehu W; Lee DC; Yi EH; Cevallos V; Zhou Z; Donnellan C; Saidel M; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2004 Aug; 292(6):721-5. PubMed ID: 15304470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing.
    Lietman TM; Gebre T; Abdou A; Alemayehu W; Emerson P; Blumberg S; Keenan JD; Porco TC
    Epidemics; 2015 Jun; 11():85-91. PubMed ID: 25979286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
    Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
    Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.